MSD
This role oversees technology and process development for the Large Molecule vaccine portfolio across discovery, pre-development, and manufacturing phases. The professional independently executes complex projects involving upstream and downstream processes, leading technology transfers between R&D and Manufacturing sites. They collaborate globally with Quality, Regulatory, and cross-functional teams to optimize production, solve manufacturing issues, and drive method development for diverse species.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD didn’t post a salary, so this is our estimate from similar listings.
MSD ends takeover talks with Revolution Medicines
1 month ago
Vaccine Drug Substance Development Scientist - VIE Contract
Sanofi
Scientist (Analytical Development, Cell Therapy)
AstraZeneca
Sr. Scientist, Preclinical Dev.
Merck & Co., Inc.
Scientist in Downstream Bioprocess Development
Zoetis
Operations Technician - 3rd shift
Merck & Co., Inc.
Associate Principal Scientist, Preclinical Dev.
Merck & Co., Inc.